76 related articles for article (PubMed ID: 3086327)
21. Cell cycle regulation of ribonucleoside diphosphate reductase activity in permeable mouse L cells and in extracts.
Kucera R; Brown CL; Paulus H
J Cell Physiol; 1983 Nov; 117(2):158-68. PubMed ID: 6355126
[TBL] [Abstract][Full Text] [Related]
22. Concanavalin A-stimulated rat spleen cells produce a soluble factor that supports growth of the mouse IL-3-dependent cell line Ea3.123, but not three other IL-3-dependent lines.
Carron JA; Marshall-Clarke S
Immunology; 1986 Aug; 58(4):635-40. PubMed ID: 3089920
[TBL] [Abstract][Full Text] [Related]
23. Rat IL-3 stimulates the growth of rat mucosal mast cells in culture.
Haig DM; McMenamin C; Redmond J; Brown D; Young IG; Cohen SD; Hapel AJ
Immunology; 1988 Oct; 65(2):205-11. PubMed ID: 3263940
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow adherent cell hemopoietic growth factor production.
Quesenberry P; Song Z; Alberico T; Gualtieri R; Stewart M; Innes D; McGrath E; Cranston S; Kleeman E
Prog Clin Biol Res; 1985; 184():247-56. PubMed ID: 3931091
[TBL] [Abstract][Full Text] [Related]
25. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand.
Mekori YA; Oh CK; Metcalfe DD
J Immunol; 1993 Oct; 151(7):3775-84. PubMed ID: 7690814
[TBL] [Abstract][Full Text] [Related]
26. Nonparenchymal cells from regenerating rat liver generate interleukin-1alpha and -1beta: a mechanism of negative regulation of hepatocyte proliferation.
Boulton R; Woodman A; Calnan D; Selden C; Tam F; Hodgson H
Hepatology; 1997 Jul; 26(1):49-58. PubMed ID: 9214451
[TBL] [Abstract][Full Text] [Related]
27. Cell cycle regulation of cloned cytolytic T cells by T cell growth factor: analysis by flow microfluorometry.
Sekaly RP; MacDonald HR; Zaech P; Nabholz M
J Immunol; 1982 Oct; 129(4):1407-14. PubMed ID: 6980934
[TBL] [Abstract][Full Text] [Related]
28. A new transgenic mouse model for the study of cell cycle control in megakaryocytes.
Thompson A; Zhao Z; Ladd D; Zimmet J; Ravid K
Stem Cells; 1996; 14 Suppl 1():181-7. PubMed ID: 11012219
[TBL] [Abstract][Full Text] [Related]
29. Evidence for specific receptors for interleukin 3 on lymphokine-dependent cell lines established from long-term bone marrow cultures.
Palaszynski EW; Ihle JN
J Immunol; 1984 Apr; 132(4):1872-8. PubMed ID: 6421927
[TBL] [Abstract][Full Text] [Related]
30. Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population.
Leung BS; Potter AH
J Cell Biochem; 1987 Jul; 34(3):213-25. PubMed ID: 3611201
[TBL] [Abstract][Full Text] [Related]
31. Control of B cell proliferation: arrest of B cells in late G1 underlies immunosuppression induced by plasma cell tumors.
Berman JE; Zolla-Pazner S
J Immunol; 1987 May; 138(9):2805-12. PubMed ID: 3494771
[TBL] [Abstract][Full Text] [Related]
32. Cyclic adenosine monophosphate promotes cell survival and retards apoptosis in a factor-dependent bone marrow-derived cell line.
Berridge MV; Tan AS; Hilton CJ
Exp Hematol; 1993 Feb; 21(2):269-76. PubMed ID: 8381088
[TBL] [Abstract][Full Text] [Related]
33. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
Levi-Schaffer F; Segal V; Barak V; Rubinchik E; Nagler A
Exp Hematol; 1997 Mar; 25(3):238-45. PubMed ID: 9091300
[TBL] [Abstract][Full Text] [Related]
34. Identification of an IL-7-associated pre-pro-B cell growth-stimulating factor (PPBSF). I. Production of the non-IL-7 component by bone marrow stromal cells from IL-7 gene-deleted mice.
McKenna SD; Chen F; Lai L; Goldschneider I
J Immunol; 1998 Mar; 160(5):2272-9. PubMed ID: 9498767
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence-activated cell sorting analysis of the induction and expression of acute thermal tolerance within the cell cycle.
Rice GC; Gray JW; Dean PN; Dewey WC
Cancer Res; 1984 Jun; 44(6):2368-76. PubMed ID: 6722776
[TBL] [Abstract][Full Text] [Related]
36. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells.
Beagley KW; Eldridge JH; Kiyono H; Everson MP; Koopman WJ; Honjo T; McGhee JR
J Immunol; 1988 Sep; 141(6):2035-42. PubMed ID: 3262647
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation.
Mekori YA; Metcalfe DD
J Immunol; 1994 Sep; 153(5):2194-203. PubMed ID: 7519644
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic characteristics of cell lines requiring interleukin 3 for growth.
Ihle JN; Keller J; Greenberger JS; Henderson L; Yetter RA; Morse HC
J Immunol; 1982 Oct; 129(4):1377-83. PubMed ID: 6809821
[TBL] [Abstract][Full Text] [Related]
39. Differential responsiveness of purified mouse c-kit+ mast cells and their progenitors to IL-3 and stem cell factor.
Lantz CS; Huff TF
J Immunol; 1995 Oct; 155(8):4024-9. PubMed ID: 7561112
[TBL] [Abstract][Full Text] [Related]
40. Effects of interleukins on EGF-stimulated growth promotion in human thyroid cells: differential modifications by IL-2 and IL-6 in Graves' and normal thyroid cells.
Shimomura N; Itoh M; Okugawa T; Murata Y; Seo H
Endocr Regul; 1994 Jun; 28(2):55-65. PubMed ID: 7949016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
